Different Outcomes of Anti-VEGF Treatment for Neovascular AMD according to Neovascular Sutypes and Baseline Features: 2-Year Real-Life Clinical Outcomes

Table 3

Stratified analysis on the basis of baseline best-corrected visual acuity. The following abbreviations are used: BCVA: best-corrected visual acuity; CMT: central macular thickness.

(a)

Stratified analysis on the basis of BCVA
		BCVA baseline	BCVA 1 y	BCVA 2 y	CMT baseline	CMT 1 y	CMT 2 y	N. IV 1 y	N. IV 2 y	TOT N. IV
	MEAN	0.178	0.181	0.2	342	308	300	6.2	3.7	9.9
	STD	0.097	0.162	0.191	83	71	65	1.6	2.2	3.2
	MEAN	0.701	0.595	0.61	416	358	314	6.0	3.3	9.3
	STD	0.279	0.403	0.408	136	105	59	1.7	2	3.3

(b)

Stratified analysis on the basis of BCVA
value		BCVA	CMT
	Baseline vs 1 y	>0.05	<0.01
		<0.01	<0.01
	Baseline vs 2 y	>0.05	<0.01
		<0.01	<0.01
	1 y vs 2 y	>0.05	0.03
		>0.05	<0.01